| Name | Title | Contact Details |
|---|
Chase Brexton is an equal opportunity employer committed to providing all employees, patients, applicants, and visitors with a safe and supportive environment. Everyone is welcomed and accepted, regardless of race, gender, nation of origin, sexual orientation, gender identity, marital status, religion, socio-economic status, veteran status, or disability. Minority applicants are strongly encouraged to apply. Part of our vision at Chase Brexton is to empower our staff and foster a culture that promotes staff development and satisfaction. We believe our staff is key to achieving our mission to provide compassionate, quality health care that honors diversity, inspires wellness, and improves our communities. Our work is not possible without a strong, devoted, and talented staff. Chase Brexton offers a comprehensive benefits package including medical and dental insurance, vacation, sick leave, paid holidays, long- and short-term disability, life insurance, tuition reimbursement, an Employee Assistance Program, and a tax-free retirement plan with company matching contributions. All in a professional, supportive environment.
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of care they deliver to patients.
AllMed Healthcare Management is a utilization management and independent review organization providing comprehensive nurse and physician review solutions to payer and provider organizations nationwide. Our clients include leading health plans, medical management organizations, TPAs, disability carriers, hospital groups and ambulatory surgery centers. Services are deployed through PeerPoint, AllMed`s state-of-the-art medical review portal.
SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.
Tokai Pharmaceuticals is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.